Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-13-025135)

Filing Details

Accession Number:: 0001127602-13-025135
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-08-14 17:57:43
Reporting Period:: 2013-08-12

Filing Date:: 2013-08-14
Accepted Time:: 2013-08-14 17:57:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1520262	Alkermes Plc.	ALKS	Pharmaceutical Preparations (2834)	981007018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1235600	J Michael Landine	852 Winter St. Waltham MA 02451	Svp, Corp Dev., Alkermes, Inc.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2013-08-12	1,500	$14.57	120,446	No	4	M	Direct
Ordinary Shares	Disposition	2013-08-12	1,500	$33.89	118,946	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Non Qualified Stock Option (Right to Buy)	Disposition	2013-08-12	1,500	$0.00	1,500	$14.57

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2013-10-17	No	4	M	Direct

Footnotes

This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
These options are fully vested in accordance with their terms.